(Q44325448)

2 December 2017

title

Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. (English)

1 reference

2 December 2017

1 reference

1 reference

Nghiem B Ha

1

1 reference

2 December 2017

Nghi B Ha

2

1 reference

2 December 2017

Ruel T Garcia

3

1 reference

2 December 2017

Huy N Trinh

4

1 reference

2 December 2017

Kevin T Chaung

5

1 reference

2 December 2017

Huy A Nguyen

6

1 reference

2 December 2017

Khanh K Nguyen

7

1 reference

2 December 2017

Brian S Levitt

8

1 reference

2 December 2017

Mindie H Nguyen

9

1 reference

2 December 2017

publication date

17 February 2011

1 reference

Digestive Diseases and Sciences

2 December 2017

published in

1 reference

2 December 2017

volume

56

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

2423-2431

1 reference

Epidemiology and natural history of hepatitis B.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Treatment of hepatitis B: the next five years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Recall of recommendations and adherence to advice among patients with chronic medical conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Patient adherence and medical treatment outcomes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Long-term patient adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Health beliefs, disease severity, and patient adherence: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Factors affecting adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1610-5

Hepatitis B virus infection

21 January 2018

1 reference

12 December 2020

Study of adherence comes to the treatment of chronic hepatitis B

1 reference

12 December 2020

Effectiveness of interventions to improve patient compliance: a meta-analysis

1 reference

12 December 2020

Chronic hepatitis B: update of recommendations

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B

1 reference

12 December 2020

Helping patients follow prescribed treatment: clinical applications

1 reference

12 December 2020

10.1007/S10620-011-1610-5

Identifiers

DOI

1 reference

2 December 2017

1 reference